Hoiby N
Biofilm. 2025; 9():100246.
PMID: 39811797
PMC: 11732244.
DOI: 10.1016/j.bioflm.2024.100246.
Jasim A, Mohammed A, Abbas W, Ibraheim H, Gharban H
Vet World. 2024; 17(7):1629-1636.
PMID: 39185049
PMC: 11344103.
DOI: 10.14202/vetworld.2024.1629-1636.
Nickerson R, Thornton C, Johnston B, Lee A, Cheng Z
Front Immunol. 2024; 15:1405376.
PMID: 39015565
PMC: 11250099.
DOI: 10.3389/fimmu.2024.1405376.
Bogyo L, Torok K, Illes Z, Szilvasi A, Szekely B, Bohacs A
Respir Res. 2024; 25(1):262.
PMID: 38951782
PMC: 11218249.
DOI: 10.1186/s12931-024-02868-1.
Chichon G, Lopez M, de Toro M, Ruiz-Roldan L, Rojo-Bezares B, Saenz Y
Antibiotics (Basel). 2023; 12(11).
PMID: 37998763
PMC: 10668709.
DOI: 10.3390/antibiotics12111561.
Battle royale: Immune response on biofilms - host-pathogen interactions.
Cangui-Panchi S, Nacato-Toapanta A, Enriquez-Martinez L, Salinas-Delgado G, Reyes J, Garzon-Chavez D
Curr Res Immunol. 2023; 4:100057.
PMID: 37025390
PMC: 10070391.
DOI: 10.1016/j.crimmu.2023.100057.
Host-Defense-Peptide-Mimicking β-Peptide Polymer Acting as a Dual-Modal Antibacterial Agent by Interfering Quorum Sensing and Killing Individual Bacteria Simultaneously.
Li W, Xiao X, Qi Y, Lin X, Hu H, Shi M
Research (Wash D C). 2023; 6:0051.
PMID: 36930779
PMC: 10014070.
DOI: 10.34133/research.0051.
Perspective: The viscoelastic properties of biofilm infections and mechanical interactions with phagocytic immune cells.
Wells M, Schneider R, Bhattarai B, Currie H, Chavez B, Christopher G
Front Cell Infect Microbiol. 2023; 13:1102199.
PMID: 36875516
PMC: 9978752.
DOI: 10.3389/fcimb.2023.1102199.
Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
Ghasemian S, Karami-Zarandi M, Heidari H, Khoshnood S, Kouhsari E, Ghafourian S
J Clin Lab Anal. 2023; 37(4):e24850.
PMID: 36808649
PMC: 10020843.
DOI: 10.1002/jcla.24850.
Immune Response to Biofilm Growing Pulmonary Infection.
Thomsen K, Hoiby N, Jensen P, Ciofu O, Moser C
Biomedicines. 2022; 10(9).
PMID: 36140163
PMC: 9495460.
DOI: 10.3390/biomedicines10092064.
: Recent Advances in Vaccine Development.
Killough M, Rodgers A, Ingram R
Vaccines (Basel). 2022; 10(7).
PMID: 35891262
PMC: 9320790.
DOI: 10.3390/vaccines10071100.
Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
Malcolm K, Wheeler E, Calhoun K, Lenhart-Pendergrass P, Rysavy N, Poch K
Microbiol Spectr. 2022; 10(4):e0187422.
PMID: 35863022
PMC: 9430546.
DOI: 10.1128/spectrum.01874-22.
An Immunoproteomic Survey of the Antibody Landscape: Insights and Opportunities Revealed by Serological Repertoire Profiling.
Ionov S, Lee J
Front Immunol. 2022; 13:832533.
PMID: 35178051
PMC: 8843944.
DOI: 10.3389/fimmu.2022.832533.
Hydrophobic Chitosan Nanoparticles Loaded with Carvacrol against Biofilms.
Bernal-Mercado A, Juarez J, Valdez M, Ayala-Zavala J, Del-Toro-Sanchez C, Encinas-Basurto D
Molecules. 2022; 27(3).
PMID: 35163966
PMC: 8839698.
DOI: 10.3390/molecules27030699.
Tolerance and resistance of microbial biofilms.
Ciofu O, Moser C, Jensen P, Hoiby N
Nat Rev Microbiol. 2022; 20(10):621-635.
PMID: 35115704
DOI: 10.1038/s41579-022-00682-4.
Potential Therapeutic Targets for Combination Antibody Therapy against Infections.
Proctor L, Ward W, Roggy C, Koontz A, Clark K, Quinn A
Antibiotics (Basel). 2021; 10(12).
PMID: 34943742
PMC: 8698887.
DOI: 10.3390/antibiotics10121530.
Planktonic and Biofilm-Associated and Elicit Differential Human Peripheral Blood Cell Responses.
Kaya E, Batoni G, Di Luca M, Apolloni E, Mazzoni A, Maisetta G
Microorganisms. 2021; 9(9).
PMID: 34576742
PMC: 8470397.
DOI: 10.3390/microorganisms9091846.
Immunoglobulin GM and KM allotypes are associated with antibody responses to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
Pandey J, Namboodiri A, Nietert P, Knowles M, Pace R, Pier G
J Cyst Fibros. 2021; 20(6):1080-1084.
PMID: 34246573
PMC: 9009249.
DOI: 10.1016/j.jcf.2021.06.011.
Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes.
Enos A, Kumar P, Lassiter B, Sampson A, Hair P, Krishna N
PLoS One. 2021; 16(7):e0254353.
PMID: 34242348
PMC: 8270186.
DOI: 10.1371/journal.pone.0254353.
Bacterial Interactions with in the Immunocompromised Lung.
Margalit A, Carolan J, Kavanagh K
Microorganisms. 2021; 9(2).
PMID: 33669831
PMC: 7923216.
DOI: 10.3390/microorganisms9020435.